Rewrite the rules

How will Brexit impact medical device regulation? Will this add barriers to approval, investment and ultimately patient access? Can new regulations create more opportunities?


JAMES FRY | Partner and Head of Life Sciences |Mills & Reeve


TIM ANDREWS | Chief Operating Officer and Commercial Director | ORCHA
KAREN TAYLOR | Director, Deloitte Centre for Health Solutions | Clients & Industries | Deloitte LLP
MICHAEL KIPPING | Innovation Lead – Biomedical Catalyst, Health Sector Team | Innovate UK
PAOLO GUERRA | MedTech Lead | ProductLife Group
ALEJANDRO (ALEX) FRANGI | Diamond Jubilee Chair in Computational Medicine | University of Leeds